中药大品种培育影响指标问卷调查报告  

Studies and reports of impact indicators on big brand Chinese medicine cultivation

作　　者：莫美 张霄潇[1] 于国华[1] 董玲[1] 杨洪军[2] 

机构地区：[1]北京中医药大学中药学院,北京100102 [2]中国中医科学院中药研究所,北京100700

出　　处：《中国中药杂志》2015年第22期4501-4505,共5页China Journal of Chinese Materia Medica

基　　金：中华中医药学会研究与评价专项(CACMRE2014-A-02);北京中医药大学创新团队发展计划项目(2011-CXTD-13)

摘　　要：在全国范围内选取30家代表性中药企业进行问卷调查,调研政策及市场准入、产品独特性及研究支撑、市场及销售能力、产品资源保障及安全性相关指标对中药大品种培育的重要性,为企业培育大品种提供参考。通过调研发现,不同受访者、不同类型企业对中药大品种培育的影响指标认识不一;企业最关注政策及市场准入机会,医保、基药等国家药物政策对大品种培育至关重要;产品的独家性为产品发展提供天然优势;学术专家团队建设日益受到重视;产品的安全性研究应得到更多关注。Questionnaire survey was conducted among thirty traditional Chinese pharmaceutical companies nationwide. We studied the following factors and how they impose the significance on the culture of big brands,namely,the policies,the access to market,the specialty of the product,the foundation of research,the market,the salesmanship,the resource insurance of product and the security.And these could be referred when the enterprises cultivate the big brands. The findings show that interviewees and different firms hold various opinions on the factors of culture of the big brands. The policies and the access to market always attract the most attention for the enterprises,and whether the product is classified into the catalogue of health insurance or into the basic medicinal directory plays a pivotal role in the development of big brand. The uniqueness of the product can be regarded as a natural advantage,the construction of team of academic experts is more and more emphasized on the development of the product,and the security of the product deserves increasing attention.

关 键 词：中药企业 中药大品种 影响指标 

分 类 号：F426.72[经济管理—产业经济]